ALNY

Alnylam Pharmaceuticals, Inc.NASDAQHealthcare

$318.85-3.01%ClosedMarket Cap: $42.29B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-25	Chardan Capital	—	Buy	—
2026-03-25	HC Wainwright & Co.	—	Buy	—
2026-03-16	Jefferies	—	Hold	—
2026-02-18	HC Wainwright & Co.	—	Buy	—
2026-02-17	Freedom Capital Markets	—	Buy	—
2026-02-17	Canaccord Genuity	—	Buy	—
2026-02-17	Freedom Broker	—	Buy	—
2026-02-13	Chardan Capital	—	Buy	—
2026-02-12	Needham	—	Buy	—
2026-01-30	B of A Securities	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$10.51	$7.35B	13
Sun Dec 31	$13.52	$8.76B	16
Mon Dec 31	$16.09	$9.98B	14
Tue Dec 31	$19.21	$11.36B	14